Get an alert when BESPAK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£25m

+6.5% vs 2024

Net assets

£364m

+17.7% vs 2024

Employees

1,249

-0.7% vs 2024

Profit before tax

£3.6m

-69.2% vs 2024

Watch the reel

Our short-form breakdown of BESPAK LIMITED's latest filing

UK medical device manufacturer Bespak grew turnover 31% to £299m, though foreign exchange losses weighed on the bottom line. 💊📉

Accounts

2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2024-12-312025-12-31 Δ vs prior
Turnover £228,500,000£299,200,000 +30.9%
Operating profit £31,200,000£70,600,000 +126.3%
Profit before tax £11,700,000£3,600,000 -69.2%
Net profit £5,400,000£1,400,000 -74.1%
Cash £23,200,000£24,700,000 +6.5%
Total assets less current liabilities £1,032,500,000£1,079,900,000 +4.6%
Net assets £309,200,000£363,900,000 +17.7%
Equity £309,200,000£363,900,000 +17.7%
Average employees 1,2581,249 -0.7%
Wages £48,500,000£60,800,000 +25.4%
Directors' remuneration £1,300,000£1,400,000 +7.7%
Directors' pension contributions £100,000£100,000 0%
Highest paid director £300,000£500,000 +66.7%

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-12-312025-12-31
Operating margin 13.7%23.6%
Net margin 2.4%0.5%
Return on capital employed 3.0%6.5%
Gearing (liabilities / total assets) 72.7%68.4%
Current ratio 1.04x1.74x
Interest cover 0.76x1.02x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
Ernst & Young
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors are confident that the Group will have sufficient funds to continue to meet its liabilities as they fall due for the period to 30 June 2027 and therefore have prepared the financial statements on a going concern basis.”

Group structure

  1. BESPAK LIMITED · parent
    1. Bespak Europe Limited 100% · England · device development, component manufacturing, fill-finish capabilities, and analytical testing
    2. Bespak HC Limited 100% · United Kingdom · device development, component manufacturing, fill-finish capabilities, and analytical testing
    3. Bespak Ventures BV 100% · Netherlands · device development, component manufacturing, fill-finish capabilities, and analytical testing
    4. Resyca 11 BV 51% · Netherlands · research and development of new medical respiratory devices
    5. Resyca BV 51% · Netherlands · research and development of new medical respiratory devices
    6. Rsyca GmbH 51% · Germany · research and development of new medical respiratory devices

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

7 active · 3 resigned

Name Role Appointed Born Nationality
FAESSLER, Ulrich Director 2024-04-01 Aug 1960 Swiss
HIRST, Christopher Anthony Director 2024-04-22 Apr 1977 British
KLUG, Oren Director 2024-04-22 Sep 1984 British
NEEVE, Maria Louise Director 2025-01-14 May 1974 British
SCHULTZ, Kare Director 2024-04-01 May 1961 Danish
WHITAKER, Anne Michelle Clem Director 2024-05-23 Jun 1967 American
WITTKOWSKI, Matthias Director 2024-04-01 Mar 1983 German
Show 3 resigned officers
Name Role Appointed Resigned
BEHAR, Greg Director 2024-04-01 2025-12-31
HIRST, Christopher Anthony Director 2024-02-02 2024-04-01
KLUG, Oren Director 2024-02-02 2024-04-01

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Eqt Ab Corporate entity Shares 75–100%, Voting 75–100% 2024-02-02 Active

Filing timeline

Last 20 of 31 total filings

Date Type Category Description
2026-08-27 SH01 capital Capital allotment shares PDF
2026-08-06 AA accounts Accounts with accounts type group
2026-08-06 MR04 mortgage Mortgage satisfy charge full PDF
2026-07-04 TM01 officers Termination director company with name termination date PDF
2026-07-04 TM01 officers Termination director company with name termination date PDF
2026-07-02 TM01 officers Termination director company with name termination date PDF
2026-07-02 TM01 officers Termination director company with name termination date PDF
2026-04-30 CH01 officers Change person director company with change date PDF
2026-04-30 CH01 officers Change person director company with change date PDF
2026-02-04 TM01 officers Termination director company with name termination date PDF
2025-11-11 CS01 confirmation-statement Confirmation statement with updates PDF
2025-08-22 AA accounts Accounts with accounts type group
2025-07-10 RP04SH01 capital Second filing capital allotment shares PDF
2025-07-10 RP04SH01 capital Second filing capital allotment shares PDF
2025-06-24 SH01 capital Capital allotment shares
2025-03-20 AP01 officers Appoint person director company with name date PDF
2025-02-19 CS01 confirmation-statement Confirmation statement with updates PDF
2024-10-02 SH01 capital Capital allotment shares PDF
2024-06-13 AP01 officers Appoint person director company with name date PDF
2024-04-25 AP01 officers Appoint person director company with name date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
11

last 12 months

Capital events
5

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page